Stock Events

Stock Events

Third Harmonic Bio 

$5.38
7
-$0-0.09% Wednesday 20:00

Statistics

Day High
5.43
Day Low
5.35
52W High
16.02
52W Low
3.18
Volume
1,042,702
Avg. Volume
259,811
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
May 14
$0.12
Feb 14
$0.12
Nov 13
$0.1
Aug 13
$0.1
Feb 13
$0.05
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

7AugExpected
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
-0.4
-0.27
-0.13
0
Expected EPS
-0.23
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
0Revenue
-45.47MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow THRD. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Vertex Pharmaceuticals
VRTX
Mkt Cap111.43B
Vertex Pharmaceuticals is a leader in treating cystic fibrosis, a space where Third Harmonic Bio could potentially compete with its novel anti-inflammatory and autoimmune therapies.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie has a strong portfolio in immunology and oncology, areas that overlap with Third Harmonic Bio's focus on developing treatments for inflammatory diseases.
Regeneron Pharmaceuticals
REGN
Mkt Cap80.54B
Regeneron Pharmaceuticals is involved in developing and commercializing treatments for eye diseases, allergic and inflammatory diseases, which aligns with Third Harmonic Bio's focus areas.
AMGEN
AMGN
Mkt Cap187.56B
Amgen focuses on human therapeutics, including treatments for inflammatory diseases, making it a direct competitor in the biotechnology space where Third Harmonic Bio operates.
Gilead Sciences
GILD
Mkt Cap173.41B
Gilead Sciences is known for its work in antiviral drugs but also has a growing presence in oncology and inflammatory diseases, competing with Third Harmonic Bio's research focus.
Biogen
BIIB
Mkt Cap26.03B
Biogen's portfolio includes treatments for neurological and neurodegenerative diseases, along with research in immunology, potentially competing with Third Harmonic Bio's pipeline.
Novartis
NVS
Mkt Cap297.32B
Novartis is a global healthcare company with a strong emphasis on research and development in pharmaceuticals, including treatments for inflammatory diseases, making it a competitor.
Pfizer
PFE
Mkt Cap161.09B
Pfizer has a broad range of products including anti-inflammatory and autoimmune disease treatments, competing in the same therapeutic areas as Third Harmonic Bio.
Merck
MRK
Mkt Cap298.84B
Merck & Co. is involved in pharmaceuticals including immunology and inflammatory diseases, areas where Third Harmonic Bio is aiming to make an impact.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson, through its pharmaceutical segment Janssen, develops treatments for a variety of conditions including inflammatory and autoimmune diseases, competing with Third Harmonic Bio.

About

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
Ms. Natalie C. Holles
Employees
31
Country
US
ISIN
US88427A1079

Listings

0 Comments

Share your thoughts

FAQ

What is Third Harmonic Bio stock price today?▼
The current price of THRD is $5.38 USD — it has decreased by -0.09% in the past 24 hours. Watch Third Harmonic Bio stock price performance more closely on the chart.
What is Third Harmonic Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Third Harmonic Bio stocks are traded under the ticker THRD.
Is Third Harmonic Bio stock price growing?▼
THRD stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Third Harmonic Bio has showed a +54.6% increase.
What is Third Harmonic Bio revenue for the last year?▼
Third Harmonic Bio revenue for the last year amounts to 0 USD.
What is Third Harmonic Bio net income for the last year?▼
THRD net income for the last year is -45.47M USD.
Does Third Harmonic Bio pay dividends?▼
Yes, THRD dividends are paid semi-annual. The last dividend per share was 0.12 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Third Harmonic Bio have?▼
As of April 06, 2026, the company has 31 employees.
In which sector is Third Harmonic Bio located?▼
Third Harmonic Bio operates in the Health Care sector.
When did Third Harmonic Bio complete a stock split?▼
Third Harmonic Bio has not had any recent stock splits.
Where is Third Harmonic Bio headquartered?▼
Third Harmonic Bio is headquartered in San Francisco, US.